Not petty at all especially if you support NWBO, because just throwing in one clear mention of DCVax or DCVax-L costs only a couple of extra characters but could make a huge difference for other people looking for options. At least Dr. Liau was mentioned so that is a clue.
We are not even talking about citation here but allusion and the coyness of people talking about DCVax-L (though in fairness getting saved does not indenture them to do NWBO’s PR work) and the ineffective PR/IR operations at NWBO are costly to potential patients and a shareholders alike, especially if there is no latent political pressure on FDA to make a fair decision because few know that a huge decision is even being made.